Novacap teams are proud to celebrate the lift of the US-FDA warning letter from the Novacyl site in Thailand.

This success is the result of a long-term work involving first of all the Bangpoo site but also all Novacyl and Novacap teams that contributed to the success of the inspection: regulatory quality, IT, purchasing, human resources, industrial, business…

This result rewards the many efforts made in the project’s change management towards a pharmaceutical culture.

Congratulations to the teams!